MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00701-022-05363-y

Медицинская библиотека · Acta neurochirurgica · 2022

Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy.

Nakamura Yawara, Inoue Akihiro, Nishikawa Masahiro, Ohnishi Takanori, Yano Hajime, Kanemura Yonehiro, Ohtsuka Yoshihiro, Ozaki Saya, Kusakabe Kosuke, Suehiro Satoshi, Yamashita Daisuke, Shigekawa Seiji, Watanabe Hideaki, Kitazawa Riko, Tanaka Junya, Kunieda Takeharu

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Increased extracellular glutamate is known to cause epileptic seizures in patients with glioblastoma (GBM). However, predicting whether the seizure will be refractory is difficult. The present study investigated whether evaluation of the levels of various metabolites, including glutamate, can predict the occurrence of refractory seizure in GBM by quantitative measurement of metabolite concentrations on magnetic resonance spectroscopy (MRS).

METHODS

Forty patients were treated according to the same treatment protocol for primary GBM at Ehime University Hospital between April 2017 and July 2021. Of these patients, 23 underwent MRS to determine concentrations of metabolites, including glutamate, N-acetylaspartate, creatine, and lactate, in the tumor periphery by applying LC-Model. The concentration of each metabolite was expressed as a ratio to creatine concentration. Patients were divided into three groups: Type A, patients with no seizures; Type B, patients with seizures that disappeared after treatment; and Type C, patients with seizures that remained unrelieved or appeared after treatment (refractory seizures). Relationships between concentrations of metabolites and seizure types were investigated.

RESULTS

In 23 GBMs, seizures were confirmed in 11 patients, including Type B in four and Type C in seven. Patients with epilepsy (Type B or C) showed significantly higher glutamate and N-acetylaspartate values than did non-epilepsy patients (Type A) (p < 0.05). No significant differences in glutamate or N-acetylaspartate levels were seen between Types B and C. Conversely, Type C showed significantly higher concentrations of lactate than did Type B (p = 0.001). Cutoff values of lactate-to-creatine, glutamate-to-creatine, and N-acetylaspartate-to-creatine ratios for refractory seizure were > 1.25, > 1.09, and > 0.88, respectively.

CONCLUSIONS

Extracellular concentrations of glutamate, N-acetylaspartate, and lactate in the tumor periphery were significantly elevated in patients with GBM with refractory seizures. Measurement of these metabolites on MRS may predict refractory epilepsy in such patients and could be an indicator for continuing the use of antiepileptic drugs.

Для цитирования: Nakamura Yawara, Inoue Akihiro, Nishikawa Masahiro, Ohnishi Takanori, Yano Hajime, Kanemura Yonehiro, Ohtsuka Yoshihiro, Ozaki Saya, Kusakabe Kosuke, Suehiro Satoshi, Yamashita Daisuke, Shigekawa Seiji, Watanabe Hideaki, Kitazawa Riko, Tanaka Junya, Kunieda Takeharu. Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy.. Acta neurochirurgica. 2022. DOI: 10.1007/s00701-022-05363-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.